Endogenous Catecholamines Flashcards

1
Q

Epinephrine Class

A

Endogenous catecholamine, non-selective adrenergic agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Epinephrine MOA

A

Direct alpha- and beta-adrenergic agonist, increased cAMP

Low doses (B2): vasodilation of skeletal muscle & ↓ SVR, bronchodilation, & ↓ histamine release

Moderate Doses (B1): ↑ HR & contractility

High doses (A1 &B): ↑ vasoconstriction = ↑ SBP, ↑CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Epinephrine Dosing (4)

A

Cardiac arrest, shock: 1 mg

Anaphylaxis: 100-500 mcg

Infusion: 2 – 20 mcg/min

Low dose infusion – beta agonism predominates

Medium dose infusion – equal beta and alpha agonism

High dose infusions – alpha agonism predominates

Mixed with local anesthetics to decrease systemic absorption 1:200,000 (5mcg/mL of epinephrine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Epinephrine Onset and DOA

A

Onset: 1 minute
Duration: 5 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Epinephrine Metabolism

A

MAO, COMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Epinephrine Excretion

A

Renally excreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Epinephrine Admin Considerations (3)

A

May cause tachycardia, arrythmias, angina, hypertension, decrease perfusion to splanchnic organs and uterus, and gangrene in digits

Avoid in peripheral nerve blocks

Caution in patients with CAD, hyperthyroidism and pheochromocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Norepinephrine Class

A

Endogenous catecholamine, adrenergic agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Norepinephrine MOA

A

Endogenous direct acting catecholamine – agonizes A1, A2 & weak B1

Increases SVR by vasoconstricting arteries and veins via A1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Norepinephrine Uses

A

First-line vasopressor for septic shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Epinephrine Uses

A

Cardiac arrest, anaphylaxis, shock states, used with LA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Norepinephrine Dosing

A

Infusion: 1 – 20 mcg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Norepinephrine Onset and DOA

A

Onset: 1 minute
DOA: 2 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Norepinephrine Metabolism

A

MAO, COMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Norepinephrine Excretion

A

Renally Excreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Norepinephrine Admin Considerations (3)

A

May cause bradycardia (baroreceptor reflex), hypertension, profound decrease perfusion to splanchnic organs and uterus

Avoid in peripheral nerve blocks

Caution in patients with hyperthyroidism, pheochromocytoma and without central IV access d/t extravasation

17
Q

Dopamine Class

A

endogenous nonselective adrenergic and dopaminergic agonist, direct and indirect acting

18
Q

Dopamine MOA

A

dopamine stimulates D receptors, β-receptors, and α-receptors in a dose-dependent manner because of differing receptor affinities

19
Q

Dopamine Uses

A

Shock
BP support
Increases U/O but does not improve renal function

20
Q

Dopamine Dosing

A

Dopaminergic receptors: 2 mcg/kg/min
β receptors: 2 to 5 mcg/kg/min
α receptors: greater than 10 mcg/kg/min

21
Q

Dopamine Onset and DOA

A

Onset: 2 minutes
DOA: 10 minutes

22
Q

Dopamine Metabolism

A

MAO and COMT

75% inactive and 25% NE

23
Q

Dopamine Excretion

A

Renally excreted

24
Q

Dopamine Admin Considerations (3)

A

Dopamine also inhibits aldosterone, resulting in an increase in sodium excretion and urine output.

Caution in patents on MAOI and TCA, tachycardia, arrythmias

r/f extravasation